product summary
Loading...
company name :
R&D Systems
product type :
other
product name :
Mouse IgG1 PE-conjugated Antibody
catalog :
IC002P
quantity :
200 Tests
price :
211 USD
more info or order :
citations: 55
Reference
Sun Y, Lin X, Liu B, Zhang Y, Li W, Zhang S, et al. Loss of ATF4 leads to functional aging-like attrition of adult hematopoietic stem cells. Sci Adv. 2021;7:eabj6877 pubmed publisher
Hall Roberts H, Agarwal D, Obst J, Smith T, Monzón Sandoval J, Di Daniel E, et al. TREM2 Alzheimer's variant R47H causes similar transcriptional dysregulation to knockout, yet only subtle functional phenotypes in human iPSC-derived macrophages. Alzheimers Res Ther. 2020;12:151 pubmed publisher
Dong Y, Lee Y, Cui K, He M, Wang B, Bhattacharjee S, et al. Epsin-mediated degradation of IP3R1 fuels atherosclerosis. Nat Commun. 2020;11:3984 pubmed publisher
Lee S, Moon H, Lee Y, Kang C, Kim S. Potentiation of TRAIL‑induced cell death by nonsteroidal anti‑inflammatory drug in human hepatocellular carcinoma cells through the ER stress‑dependent autophagy pathway. Oncol Rep. 2020;44:1136-1148 pubmed publisher
Donninelli G, Saraf Sinik I, Mazziotti V, Capone A, Grasso M, Battistini L, et al. Interleukin-9 regulates macrophage activation in the progressive multiple sclerosis brain. J Neuroinflammation. 2020;17:149 pubmed publisher
Troschel F, Minte A, Ismail Y, Kamal A, Abdullah M, Ahmed S, et al. Knockdown of Musashi RNA Binding Proteins Decreases Radioresistance but Enhances Cell Motility and Invasion in Triple-Negative Breast Cancer. Int J Mol Sci. 2020;21: pubmed publisher
Costa S, Gomes V, Dos Santos Maciel M, Melo L, Venturin G, Bragato J, et al. Combined in vitro IL-12 and IL-15 stimulation promotes cellular immune response in dogs with visceral leishmaniasis. PLoS Negl Trop Dis. 2020;14:e0008021 pubmed publisher
Aleisa F, Sakashita K, Lee J, AbuSamra D, Al Alwan B, Nozue S, et al. Functional binding of E-selectin to its ligands is enhanced by structural features beyond its lectin domain. J Biol Chem. 2020;295:3719-3733 pubmed publisher
Queckborner S, Syk Lundberg E, Gemzell Danielsson K, Davies L. Endometrial stromal cells exhibit a distinct phenotypic and immunomodulatory profile. Stem Cell Res Ther. 2020;11:15 pubmed publisher
Hsiao M, Lin P, Liao W, Chen W, Hsu C, He C, et al. The Effect of the Repression of Oxidative Stress on Tenocyte Differentiation: A Preliminary Study of a Rat Cell Model Using a Novel Differential Tensile Strain Bioreactor. Int J Mol Sci. 2019;20: pubmed publisher
Hyun J, McMahon R, Lang A, Edwards J, Badilla A, Greene M, et al. HIV and HCV augments inflammatory responses through increased TREM-1 expression and signaling in Kupffer and Myeloid cells. PLoS Pathog. 2019;15:e1007883 pubmed publisher
Umrath F, Steinle H, Weber M, Wendel H, Reinert S, Alexander D, et al. Generation of iPSCs from Jaw Periosteal Cells Using Self-Replicating RNA. Int J Mol Sci. 2019;20: pubmed publisher
Siddiqui M, Railkar R, Sanford T, Crooks D, Eckhaus M, Haines D, et al. Targeting Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor 2 (HER2) Expressing Bladder Cancer Using Combination Photoimmunotherapy (PIT). Sci Rep. 2019;9:2084 pubmed publisher
Shi L, Li Y, Dai G, Lin Y, Li G, Wang C, et al. Impaired function of tendon-derived stem cells in experimental diabetes mellitus rat tendons: implications for cellular mechanism of diabetic tendon disorder. Stem Cell Res Ther. 2019;10:27 pubmed publisher
Walwyn Brown K, Guldevall K, Saeed M, Pende D, Önfelt B, MacDonald A, et al. Human NK Cells Lyse Th2-Polarizing Dendritic Cells via NKp30 and DNAM-1. J Immunol. 2018;201:2028-2041 pubmed publisher
De Pauw I, Lardon F, Van den Bossche J, Baysal H, Fransen E, Deschoolmeester V, et al. Simultaneous targeting of EGFR, HER2, and HER4 by afatinib overcomes intrinsic and acquired cetuximab resistance in head and neck squamous cell carcinoma cell lines. Mol Oncol. 2018;12:830-854 pubmed publisher
Chua B, Ngo J, Situ K, Ramirez C, Nakano H, Morizono K. Protein S and Gas6 induce efferocytosis of HIV-1-infected cells. Virology. 2018;515:176-190 pubmed publisher
Zhang H, Wang J, Wang L, Xie H, Chen L, He S. Role of IL-18 in atopic asthma is determined by balance of IL-18/IL-18BP/IL-18R. J Cell Mol Med. 2018;22:354-373 pubmed publisher
Uchibori T, Matsuda K, Shimodaira T, Sugano M, Uehara T, Honda T. IL-6 trans-signaling is another pathway to upregulate Osteopontin. Cytokine. 2017;90:88-95 pubmed publisher
Nicolazzo C, Raimondi C, Mancini M, Caponnetto S, Gradilone A, Gandini O, et al. Monitoring PD-L1 positive circulating tumor cells in non-small cell lung cancer patients treated with the PD-1 inhibitor Nivolumab. Sci Rep. 2016;6:31726 pubmed publisher
Steiger J, Stephan A, Inkeles M, Realegeno S, Bruns H, Kröll P, et al. Imatinib Triggers Phagolysosome Acidification and Antimicrobial Activity against Mycobacterium bovis Bacille Calmette-Guérin in Glucocorticoid-Treated Human Macrophages. J Immunol. 2016;197:222-32 pubmed publisher
Pillay S, Meyer N, Puschnik A, Davulcu O, Diep J, Ishikawa Y, et al. An essential receptor for adeno-associated virus infection. Nature. 2016;530:108-12 pubmed publisher
Jarantow S, Bushey B, Pardinas J, Boakye K, Lacy E, Sanders R, et al. Impact of Cell-surface Antigen Expression on Target Engagement and Function of an Epidermal Growth Factor Receptor × c-MET Bispecific Antibody. J Biol Chem. 2015;290:24689-704 pubmed publisher
Ahn S, Edwards A, Singh S, Young S, Lessey B, Tayade C. IL-17A Contributes to the Pathogenesis of Endometriosis by Triggering Proinflammatory Cytokines and Angiogenic Growth Factors. J Immunol. 2015;195:2591-600 pubmed publisher
Fairclough L, Stoop A, Negm O, Radford P, Tighe P, Todd I. Tumour necrosis factor receptor I blockade shows that TNF-dependent and TNF-independent mechanisms synergise in TNF receptor associated periodic syndrome. Eur J Immunol. 2015;45:2937-44 pubmed publisher
Le Q, Blanchet M, Seidah N, Labonté P. Plasma Membrane Tetraspanin CD81 Complexes with Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) and Low Density Lipoprotein Receptor (LDLR), and Its Levels Are Reduced by PCSK9. J Biol Chem. 2015;290:23385-400 pubmed publisher
Mercer J, Argus J, Crabtree D, KEENAN M, Wilks M, Chi J, et al. Modulation of PICALM Levels Perturbs Cellular Cholesterol Homeostasis. PLoS ONE. 2015;10:e0129776 pubmed publisher
Anguille S, Van Acker H, Van den Bergh J, Willemen Y, Goossens H, Van Tendeloo V, et al. Interleukin-15 Dendritic Cells Harness NK Cell Cytotoxic Effector Function in a Contact- and IL-15-Dependent Manner. PLoS ONE. 2015;10:e0123340 pubmed publisher
Yamada T, Abei M, Danjoh I, Shirota R, Yamashita T, Hyodo I, et al. Identification of a unique hepatocellular carcinoma line, Li-7, with CD13(+) cancer stem cells hierarchy and population change upon its differentiation during culture and effects of sorafenib. BMC Cancer. 2015;15:260 pubmed publisher
Warat M, Sadowski T, Szliszka E, Krol W, Czuba Z. The role of selected flavonols in tumor necrosis factor-related apoptosis-inducing ligand receptor-1 (TRAIL-R1) expression on activated RAW 264.7 macrophages. Molecules. 2015;20:900-12 pubmed publisher
Huang L, Nakayama H, Klagsbrun M, Mulliken J, Bischoff J. Glucose transporter 1-positive endothelial cells in infantile hemangioma exhibit features of facultative stem cells. Stem Cells. 2015;33:133-45 pubmed publisher
Wei F, Leung K, Li G, Qin J, Chow S, Huang S, et al. Low intensity pulsed ultrasound enhanced mesenchymal stem cell recruitment through stromal derived factor-1 signaling in fracture healing. PLoS ONE. 2014;9:e106722 pubmed publisher
Warat M, Szliszka E, Korzonek Szlacheta I, Krol W, Czuba Z. Chrysin, apigenin and acacetin inhibit tumor necrosis factor-related apoptosis-inducing ligand receptor-1 (TRAIL-R1) on activated RAW264.7 macrophages. Int J Mol Sci. 2014;15:11510-22 pubmed publisher
Mesti T, Savarin P, Triba M, Le Moyec L, Ocvirk J, Banissi C, et al. Metabolic impact of anti-angiogenic agents on U87 glioma cells. PLoS ONE. 2014;9:e99198 pubmed publisher
Mancini M, Gariboldi M, Taiana E, Bonzi M, Craparotta I, Pagin M, et al. Co-targeting the IGF system and HIF-1 inhibits migration and invasion by (triple-negative) breast cancer cells. Br J Cancer. 2014;110:2865-73 pubmed publisher
Ekert J, Johnson K, Strake B, Pardinas J, Jarantow S, Perkinson R, et al. Three-dimensional lung tumor microenvironment modulates therapeutic compound responsiveness in vitro--implication for drug development. PLoS ONE. 2014;9:e92248 pubmed publisher
Zhu Z, Meng K, Zhong Y, Qi L, Mao X, Yu K, et al. Impaired circulating CD4+ LAP+ regulatory T cells in patients with acute coronary syndrome and its mechanistic study. PLoS ONE. 2014;9:e88775 pubmed publisher
Kim S, Woo J, Jeong C, Ryu C, Jang J, Jeun S. Potential application of temozolomide in mesenchymal stem cell-based TRAIL gene therapy against malignant glioma. Stem Cells Transl Med. 2014;3:172-82 pubmed publisher
Mimura K, Shiraishi K, Mueller A, Izawa S, Kua L, So J, et al. The MAPK pathway is a predominant regulator of HLA-A expression in esophageal and gastric cancer. J Immunol. 2013;191:6261-72 pubmed publisher
Gojo I, Tan M, Fang H, Sadowska M, Lapidus R, Baer M, et al. Translational phase I trial of vorinostat (suberoylanilide hydroxamic acid) combined with cytarabine and etoposide in patients with relapsed, refractory, or high-risk acute myeloid leukemia. Clin Cancer Res. 2013;19:1838-51 pubmed publisher
Ray S, Ju X, Sun H, Finnerty C, Herndon D, Brasier A. The IL-6 trans-signaling-STAT3 pathway mediates ECM and cellular proliferation in fibroblasts from hypertrophic scar. J Invest Dermatol. 2013;133:1212-20 pubmed publisher
Andersson S, Svensson M, Erlandsson M, Dehlin M, Andersson K, Bokarewa M. Activation of Fms-like tyrosine kinase 3 signaling enhances survivin expression in a mouse model of rheumatoid arthritis. PLoS ONE. 2012;7:e47668 pubmed publisher
Müller E, Dunstheimer D, Klammt J, Friebe D, Kiess W, Kratzsch J, et al. Clinical and functional characterization of a patient carrying a compound heterozygous pericentrin mutation and a heterozygous IGF1 receptor mutation. PLoS ONE. 2012;7:e38220 pubmed publisher
Szliszka E, Helewski K, Mizgala E, Krol W. The dietary flavonol fisetin enhances the apoptosis-inducing potential of TRAIL in prostate cancer cells. Int J Oncol. 2011;39:771-9 pubmed publisher
Ball S, Bayley C, Shuttleworth C, Kielty C. Neuropilin-1 regulates platelet-derived growth factor receptor signalling in mesenchymal stem cells. Biochem J. 2010;427:29-40 pubmed publisher
Inagaki A, Ishida T, Yano H, Ishii T, Kusumoto S, Ito A, et al. Expression of the ULBP ligands for NKG2D by B-NHL cells plays an important role in determining their susceptibility to rituximab-induced ADCC. Int J Cancer. 2009;125:212-21 pubmed publisher
Heath D, Chantry A, Buckle C, Coulton L, Shaughnessy J, Evans H, et al. Inhibiting Dickkopf-1 (Dkk1) removes suppression of bone formation and prevents the development of osteolytic bone disease in multiple myeloma. J Bone Miner Res. 2009;24:425-36 pubmed publisher
Sveinbjörnsson B, Rasmuson A, Baryawno N, Wan M, Pettersen I, Ponthan F, et al. Expression of enzymes and receptors of the leukotriene pathway in human neuroblastoma promotes tumor survival and provides a target for therapy. FASEB J. 2008;22:3525-36 pubmed publisher
Vroling L, Yuana Y, Schuurhuis G, van Hinsbergh V, Gundy C, de Haas R, et al. VEGFR2 expressing circulating (progenitor) cell populations in volunteers and cancer patients. Thromb Haemost. 2007;98:440-50 pubmed
Hundhausen C, Schulte A, Schulz B, Andrzejewski M, Schwarz N, von Hundelshausen P, et al. Regulated shedding of transmembrane chemokines by the disintegrin and metalloproteinase 10 facilitates detachment of adherent leukocytes. J Immunol. 2007;178:8064-72 pubmed
Ball S, Shuttleworth C, Kielty C. Vascular endothelial growth factor can signal through platelet-derived growth factor receptors. J Cell Biol. 2007;177:489-500 pubmed
Alisa A, Ives A, Pathan A, Navarrete C, Williams R, Bertoletti A, et al. Analysis of CD4+ T-Cell responses to a novel alpha-fetoprotein-derived epitope in hepatocellular carcinoma patients. Clin Cancer Res. 2005;11:6686-94 pubmed
Gould W, Baxi S, Schroeder R, Peng Y, Leadley R, Peterson J, et al. Gas6 receptors Axl, Sky and Mer enhance platelet activation and regulate thrombotic responses. J Thromb Haemost. 2005;3:733-41 pubmed
Epelman S, Stack D, Bell C, Wong E, Neely G, Krutzik S, et al. Different domains of Pseudomonas aeruginosa exoenzyme S activate distinct TLRs. J Immunol. 2004;173:2031-40 pubmed
Dror Y, Durie P, Ginzberg H, Herman R, Banerjee A, Champagne M, et al. Clonal evolution in marrows of patients with Shwachman-Diamond syndrome: a prospective 5-year follow-up study. Exp Hematol. 2002;30:659-69 pubmed
image
image 1 :
R&D Systems IC002P image 1
Detection of Mouse IgG Isotype Control by Flow Cytometry
product information
brand :
R&D Systems
master code :
IC002P
SKU :
IC002P
product name :
Mouse IgG1 PE-conjugated Antibody
unit size :
200 Tests
description :
The Mouse IgG1 Alexa Fluor® 647-conjugated Antibody from R&D Systems is a mouse monoclonal control for IgG1. This control reacts with mouse. The Mouse IgG1 Alexa Fluor® 647-conjugated Antibody has been validated for the following applications: Control.
target :
IgG1
category :
Isotype Controls
alt names :
IgG1, Igh-4, RGD1359539, VH7183
buffer :
Supplied in a saline solution containing BSA and Sodium Azide.
clonality :
Monoclonal
clone :
11711
conjugate :
Phycoerythrin
all available conjugate :
Phycoerythrin
host :
Mouse
immunogen :
KLH
isotype :
IgG1 Kappa
purity :
Protein A or G purified from hybridoma culture supernatant
species :
Mouse
specificity :
Selected for use as mouse IgG1 isotype control for flow cytometry applications
storage :
Protect from light. Do not freeze. 12 months from date of receipt, 2 to 8 °C as supplied.
gene symbol :
IGHG1
applications :
Control
USD :
195
Jul-22 :
211 USD
sizes available :
200 Tests
more info or order :
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.